Capital Research holds 6.9% stake in Ovintiv
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Capital Research Global Investors, a division of Capital Research and Management Company and related investment management entities, reports beneficial ownership of 19,459,649 shares of Ovintiv Inc. common stock on a Schedule 13G. This represents 6.9% of the 281,018,601 shares of Ovintiv common stock believed to be outstanding as of June 30, 2026.
Capital Research Global Investors has sole voting and sole dispositive power over all 19,459,649 shares, with no shared voting or dispositive power reported. The filing reflects a passive ownership position rather than a control-seeking stake.
Key Figures
Key Terms
beneficial owner financial
Sole Voting Power financial
Sole Dispositive Power financial
Schedule 13G regulatory
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Ovintiv Inc. (OVV) does Capital Research Global Investors own?
What type of filing did Capital Research Global Investors submit for Ovintiv Inc. (OVV)?
Who signed the Ovintiv Inc. (OVV) Schedule 13G for Capital Research Global Investors?
AI-generated analysis. How Rhea-AI works. Not financial advice.